Lab
Medical Education Assistance Corporation
Medical Education Assistance Corporation was paid $2.01M by Medicaid between Jan 2018 and Dec 2024, across 63 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 40% of everything it billed.
33Billing provider infoMEDICAL EDUCATION ASSISTANCE CORPORATION
MOUNTAIN HOME, TN 37684
MOUNTAIN HOME, TN 37684
33aNPI1235236613assigned 09/20/2006
33bProvider typeClinical Medical Laboratory
28Total paid$2.01M
24GClaims159,161
24DCodes billed63
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Tennessee
Rank by total paid#22 of 70
Median peer was paid$141K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,642 | $100K | |
| 2019 | 13,592 | $116K | |
| 2020 | 18,301 | $189K | |
| 2021 | 31,033 | $643K | |
| 2022 | 25,274 | $471K | |
| 2023 | 29,319 | $267K | |
| 2024incomplete | 32,000 | $221K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 40% | 11,263 | 9,565 | $801K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 12% | 10,171 | 8,622 | $232K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 7.5% | 8,455 | 5,582 | $151K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.7% | 8,437 | 5,581 | $95K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.7% | 24,071 | 19,712 | $94K |
| 80050 | General health panel | 2.6% | 2,730 | 1,891 | $52K |
| 87660 | 2.2% | 3,758 | 2,746 | $44K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.2% | 3,025 | 2,339 | $43K |
| 87480 | 2.2% | 3,761 | 2,747 | $43K | |
| 80053 | Comprehensive metabolic panel | 2.1% | 11,173 | 8,705 | $43K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.0% | 6,703 | 5,043 | $40K |
| 87653 | 1.7% | 1,607 | 1,313 | $35K |
51 more codes
| 87510 | 1.7% | 3,761 | $34K | |
| 80061 | Lipid panel | 1.4% | 6,183 | $29K |
| 87806 | 1.3% | 1,825 | $27K | |
| 86762 | 1.3% | 2,999 | $26K | |
| 86803 | 1.1% | 3,066 | $23K | |
| 87340 | 1.1% | 4,068 | $23K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.1% | 764 | $22K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,634 | $17K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,462 | $14K |
| 84439 | <1% | 3,434 | $13K | |
| 86592 | <1% | 3,940 | $10K | |
| 84702 | <1% | 1,371 | $9K | |
| 82728 | <1% | 1,293 | $8K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,422 | $7K |
| 87081 | <1% | 1,607 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 991 | $6K |
| 86140 | <1% | 2,384 | $5K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 154 | $5K |
| 82607 | <1% | 837 | $5K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 232 | $5K |
| 85652 | <1% | 2,916 | $4K | |
| 83001 | <1% | 342 | $3K | |
| 83550 | <1% | 842 | $3K | |
| 85027 | <1% | 647 | $3K | |
| 83540 | <1% | 983 | $3K | |
| 84146 | <1% | 261 | $3K | |
| 82570 | <1% | 1,326 | $2K | |
| 84550 | <1% | 946 | $2K | |
| 82565 | <1% | 917 | $2K | |
| 82043 | <1% | 1,100 | $2K | |
| 81001 | <1% | 1,474 | $2K | |
| 85007 | <1% | 640 | $2K | |
| 83615 | <1% | 508 | $1K | |
| 84156 | <1% | 633 | $1K | |
| 83002 | <1% | 106 | $1K | |
| 80076 | <1% | 224 | $822.04 | |
| 87186 | <1% | 107 | $580.58 | |
| 83735 | <1% | 235 | $556.48 | |
| 82247 | <1% | 257 | $521.02 | |
| 84403 | <1% | 40 | $492.54 | |
| 82550 | <1% | 189 | $472.92 | |
| 84100 | <1% | 252 | $380.69 | |
| 86769 | <1% | 13 | $379.17 | |
| 81003 | <1% | 365 | $315.40 | |
| 82784 | <1% | 16 | $214.58 | |
| 82105 | <1% | 37 | $167.88 | |
| 87070 | <1% | 25 | $139.09 | |
| 82248 | <1% | 48 | $124.78 | |
| 87088 | <1% | 16 | $78.04 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 79 | $72.23 |
| 84520 | <1% | 36 | $64.74 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEWIS, RUSSELL (EXECUTIVE DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Medical Education Assistance Corporation | Johnson City, TN | $30.95M |
| Medical Education Assistance Corporation | Johnson City, TN | $9K |
| Medical Education Assistance Corporation | Mountain Home, TN | $9K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.